ANVS
Annovis Bio
$12.74
Earnings Summary
Revenue | $0Mn |
Net Profits | $-22.21Mn |
Net Profit Margins | -Inf% |
Highlights
Annovis Bio’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Annovis Bio has generated NaN% jump in its revenue since last 3-months.
Annovis Bio’s net profit fell -635.39% since last year same period to $-22.21Mn in the Q4 2023. On a quarterly growth basis, Annovis Bio has generated -50.94% fall in its net profits since last 3-months.
Annovis Bio’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Annovis Bio has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Annovis Bio post its latest quarter earnings
EPS Estimate Current Quarter | -0.69 |
EPS Estimate Current Year | -0.69 |
Highlights
Annovis Bio’s earning per share (EPS) estimates for the current quarter stand at -0.69 - a 46.92% jump from last quarter’s estimates.
Annovis Bio’s earning per share (EPS) estimates for the current year stand at -0.69.
Key Ratios
Key ratios of the Annovis Bio post its Q1 2024 earnings
Earning Per Share (EPS) | -2.33 |
Highlights
Annovis Bio’s earning per share (EPS) fell -95.97% since last year same period to -2.33 in the Q1 2024. This indicates that the Annovis Bio has generated -95.97% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-09 | -0.69 | -2.33 | -237.97% |
₹0 US Stocks a/c Opening Fee